Assignee
EXELA PHARMA SCIENCES LLC
US·23 granted patents·2 pending applications·139 citations·filing 2019–2025
Top patents by PatentIndex Score
25 records- 0198US10478453B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2019·Granted Nov 19, 2019·22 cites·22 claims
- 0297US11510942B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2021·Granted Nov 29, 2022·9 cites·34 claims
- 0397US11510941B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2021·Granted Nov 29, 2022·11 cites·17 claims
- 0497US10933089B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Mar 2, 2021·13 cites·27 claims
- 0597US10918662B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Feb 16, 2021·13 cites·29 claims
- 0697US10912795B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Feb 9, 2021·13 cites·29 claims
- 0797US10905713B2Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Feb 2, 2021·13 cites·27 claims
- 0897US10905714B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Feb 2, 2021·13 cites·29 claims
- 0997US10653719B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2020·Granted May 19, 2020·14 cites·27 claims
- 1097US10583155B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2019·Granted Mar 10, 2020·15 cites·30 claims
- 1193US12569513B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2024·Granted Mar 10, 2026·0 cites·28 claims
- 1293US11266621B1Methocarbamol composition and related methodsEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Mar 8, 2022·2 cites·21 claims
- 1392US12186338B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2024·Granted Jan 7, 2025·0 cites·21 claims
- 1492US12171781B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2024·Granted Dec 24, 2024·0 cites·30 claims
- 1591US11969439B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2023·Granted Apr 30, 2024·0 cites·30 claims
- 1689US11826383B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2023·Granted Nov 28, 2023·0 cites·30 claims
- 1787US11648262B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2022·Granted May 16, 2023·0 cites·30 claims
- 1887US11642370B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2022·Granted May 9, 2023·0 cites·30 claims
- 1986US11684636B1Stable, highly pure l-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2022·Granted Jun 27, 2023·0 cites·30 claims
- 2085US11679125B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2022·Granted Jun 20, 2023·0 cites·27 claims
- 2184US11672824B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2022·Granted Jun 13, 2023·0 cites·30 claims
- 2281US11723978B2Ganciclovir compositions and related methodsEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Aug 15, 2023·1 cites·18 claims
- 2381US2025319189A1Ganciclovir compositions and related methodsEXELA PHARMA SCIENCES LLC·Filed 2024·Application pending·0 cites
- 2478US2024181064A1Ganciclovir compositions and related methodsEXELA PHARMA SCIENCES LLC·Filed 2023·Application pending·0 cites
- 2577US12569514B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2025·Granted Mar 10, 2026·0 cites·28 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →